Novartis | NOVN - Net Income

Stock Price
110.96
Daily Change
-3.12 -2.73%
Monthly
-7.39%
Yearly
17.78%
Q2 Forecast
111.47

Novartis reported $2.41B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Alcon AG USD 217M 20M Dec/2025
Almirall EUR 19.58M 7M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
AstraZeneca USD 2.33B 207M Dec/2025
Autolus Therapeutics Ltd USD -90.33M 11.21M Dec/2025
Bayer EUR -3.76B 2.79B Dec/2025
Biogen USD 466.5M 168.3M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 327M 52.2M Dec/2025
Galapagos EUR 782.15M 984.26M Dec/2025
Genmab DKK 31M 370M Dec/2025
Gilead Sciences USD 2.18B 869M Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
GRIFOLS EUR 98.25M 28.72M Dec/2025
Hikma Pharmaceutical USD 164M 45M Dec/2025
J&J USD 5.24B 119M Mar/2026
Lonza CHF 426M 119M Jun/2025
Merck EUR 319M 583M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Novartis USD 2.41B 1.52B Dec/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Orion EUR 90.4M 170.1M Mar/2026
Pfizer USD -1.65B 5.19B Dec/2025
Philips EUR 395M 211M Dec/2025
Recordati EUR 117.31M 7.15M Dec/2025
Regeneron Pharmaceuticals USD 844.6M 615.4M Dec/2025
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
UCB EUR 1.08B 608M Dec/2025